Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2015-07-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
继续停牌公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the continued suspension of trading of its stock due to ongoing negotiations for a major acquisition. It mentions the stock suspension start date and the reason for the suspension, with a promise to update every five trading days. There is no financial data, no detailed report, no voting results, no management changes, and no earnings information. The document is an official regulatory announcement about trading suspension and ongoing material event disclosure. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2015-07-21 Chinese
继续停牌公告
Regulatory Filings Classification · 100% confidence The document is a short announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the continued suspension of trading of its stock due to ongoing negotiations for a major acquisition. It states the stock has been suspended since July 8, 2015, and will continue to be suspended until the major matter is resolved and announced. The document is brief (566 characters) and serves as a regulatory update on trading status and ongoing material event negotiations. It does not contain financial statements, audit information, voting results, or detailed report content. It is not a full report but a regulatory announcement about trading suspension and ongoing material event disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-07-14 Chinese
关于积极响应中国上市公司协会倡议的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. It states the company's commitment to not reduce stock holdings by directors and senior management for six months, and to strengthen information disclosure and investor relations. There is no financial data, no report attached or referenced as being published, and no mention of regulatory filings or detailed financial results. The document is a regulatory announcement about insider shareholding intentions and corporate governance commitments, not a financial report or meeting material. Given the content and length, it fits best as a Regulatory Filing (RNS).
2015-07-08 Chinese
停牌公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the suspension of trading of its stock due to ongoing negotiations for a major acquisition. It states the stock will be suspended until the major matter is confirmed and announced. There is no financial data, no detailed report, no voting results, or other detailed disclosures. The document is an official notice about a trading halt related to a potential M&A event but does not itself contain merger details or filings. Given the short length (501 characters) and the nature of the content, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about trading suspension and potential material event, but not a full M&A filing or report.
2015-07-07 Chinese
独立董事关于向全资子公司提供借款的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from independent directors regarding a loan to a wholly owned subsidiary. It references regulatory guidelines and company articles but does not contain financial statements or detailed financial data. The document is short (543 characters) and serves as a formal opinion or statement rather than a full report. It does not fit categories like Annual Report, Interim Report, or Audit Report. It is not a management change, earnings release, or capital update. The content aligns best with a Regulatory Filing (RNS) as it is a compliance-related disclosure without substantive financial data or report content.
2015-06-29 Chinese
关于向全资子公司提供借款的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the provision of a loan from the parent company to its wholly-owned subsidiary. It details the loan amount, purpose, terms, and approvals by the board and independent directors. There are no financial statements or comprehensive financial data presented. The document is a corporate announcement about financing activity within the group, specifically a loan to a subsidiary. This fits the category of Capital/Financing Update (CAP). The document length is short (1622 characters), and it is not a report or a certification but a specific financing announcement.
2015-06-29 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.